Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The outer membrane protein complex (OMPC) of Neisseria meningitidis serogroup B is a highly immunogenic, high-molecular-weight lipoprotein-lipopolysaccharide complex derived from the bacterial outer membrane. It is widely utilized as a carrier protein in glycoconjugate vaccines, such as PedvaxHIB and Vaxelis, where it is covalently linked to poorly immunogenic bacterial capsular polysaccharides (e.g., Haemophilus influenzae type b polyribosylribitol phosphate). By conjugating these T-cell-independent polysaccharide antigens to OMPC, the vaccine converts them into T-cell-dependent antigens, which stimulates helper T-cells, promotes immunoglobulin class switching (IgM to IgG), and establishes long-term immunological memory in infants and young children. Additionally, OMPC possesses intrinsic adjuvant activity through its robust engagement of Toll-like receptor 2 (TLR2), which further enhances the host's immune response. While highly effective in preventing invasive diseases like meningitis and sepsis, safety concerns are primarily limited to transient vaccine-related adverse events such as fever, irritability, and injection-site reactions.
Acts as a T-cell dependent carrier protein when conjugated to polysaccharide antigens, converting T-independent antigens into T-dependent antigens to stimulate robust antibody production, immunological memory, and class switching (IgM to IgG) in infants. It also engages Toll-like receptor 2 (TLR2) to provide intrinsic adjuvant activity, enhancing the immune response.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer membrane protein complex of Neisseria meningitidis serogroup B (OMPC).